Literature DB >> 22804865

Geographical distribution of salmonid alphavirus subtypes in marine farmed Atlantic salmon, Salmo salar L., in Scotland and Ireland.

D A Graham1, E Fringuelli, H M Rowley, D Cockerill, D I Cox, T Turnbull, H Rodger, D Morris, M F Mc Loughlin.   

Abstract

Sequence data from salmonid alphavirus (SAV) strains obtained from farmed marine Atlantic salmon, Salmo salar L. , over a 20-year period between 1991 and 2011 was reviewed to examine the geographical distribution of the genetically defined SAV subtypes in twelve regions across Ireland and Scotland. Of 160 different Atlantic salmon SAV strains examined, 62 belonged to subtype 1, 28 to subtype 2, 34 to subtype 4, 35 to subtype 5 and 1 to subtype 6. SAV subtypes 1, 4 and 6 were found in Ireland, while subtypes 1, 2, 4 and 5 were found in Scotland. In the majority of regions, there was a clear clustering of subtypes, with SAV subtype 1 being the dominant subtype in Ireland overall, as well as in Argyll and Bute in Scotland. SAV subtype 2 predominated in the Shetland and Orkney Islands. The emergence in Atlantic salmon of subtype 2 strains typically associated with sleeping disease in rainbow trout in Argyll and Bute, strongly suggesting transmission of infection between these species, was noted for the first time. SAV subtype 4 was the most common subtype found in the southern Western Isles, while SAV subtype 5 predominated in the northern Western Isles and north-west mainland Scotland. No single strain was dominant on sites in the western Highlands, with a number of sites in this region in particular having more than one subtype detected in different submissions. The significance of these results in relation to aspects of the epidemiology of infection, including transmission, biosecurity and wildlife reservoirs are discussed and knowledge gaps identified.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22804865     DOI: 10.1111/j.1365-2761.2012.01401.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  7 in total

1.  Mapping and validation of a major QTL affecting resistance to pancreas disease (salmonid alphavirus) in Atlantic salmon (Salmo salar).

Authors:  S Gonen; M Baranski; I Thorland; A Norris; H Grove; P Arnesen; H Bakke; S Lien; S C Bishop; R D Houston
Journal:  Heredity (Edinb)       Date:  2015-05-20       Impact factor: 3.821

2.  Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system.

Authors:  Mia C Hikke; Marjan Verest; Just M Vlak; Gorben P Pijlman
Journal:  Microb Biotechnol       Date:  2014-01-14       Impact factor: 5.813

3.  Salmonid Alphavirus (SAV).

Authors:  Izabela Deperasińska; Patrycja Schulz; Andrzej K Siwicki
Journal:  J Vet Res       Date:  2018-03-30       Impact factor: 1.744

4.  Identification of genetic loci associated with higher resistance to pancreas disease (PD) in Atlantic salmon (Salmo salar L.).

Authors:  Borghild Hillestad; Shokouh Makvandi-Nejad; Aleksei Krasnov; Hooman K Moghadam
Journal:  BMC Genomics       Date:  2020-06-03       Impact factor: 3.969

5.  Emergence of Salmonid Alphavirus Genotype 2 in Norway-Molecular Characterization of Viral Strains Circulating in Norway and Scotland.

Authors:  Monika J Hjortaas; Elena Fringuelli; Adérito L Monjane; Aase B Mikalsen; Christine M Jonassen; Paul Savage; Hilde Sindre
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

6.  The serum proteome of Atlantic salmon, Salmo salar, during pancreas disease (PD) following infection with salmonid alphavirus subtype 3 (SAV3).

Authors:  M Braceland; R Bickerdike; J Tinsley; D Cockerill; M F Mcloughlin; D A Graham; R J Burchmore; W Weir; C Wallace; P D Eckersall
Journal:  J Proteomics       Date:  2013-10-18       Impact factor: 4.044

7.  Mutation of N-glycosylation Sites in Salmonid Alphavirus (SAV) Envelope Proteins Attenuate the Virus in Cell Culture.

Authors:  Ida Aksnes; Turhan Markussen; Stine Braaen; Espen Rimstad
Journal:  Viruses       Date:  2020-09-24       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.